The Jagiellonian University is a public research university in Kraków, Poland. Founded in 1364 by King Casimir III the Great, it is the oldest university in Poland and the 13th oldest university in continuous operation in the world. It is often regarded as Poland's most prestigious academic institution.

During the past decade, Jagiellonian University conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jagiellonian University" #1 sponsor was "Elixir Medical Corporation" with 2 trials, followed by "Respicardia, Inc." with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "BioVentrix" with 1 trials sponsored and "CSL Behring" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jagiellonian University" #1 collaborator was "Jagiellonian University" with 2 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Advance Research Associates" with 1 trials as a collaborator, "Ankara University" with 1 trials as a collaborator and "CDI Centro Diagnostico Italiano" with 1 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Jagiellonian University" are "Coronary Artery Disease" (3 trials), "Heart Failure" (2 trials), "Breast Cancer" (1 trials), "Central Sleep Apnea" (1 trials) and "Cheyne Stokes Respiration" (1 trials). Many other conditions were trialed in "Jagiellonian University" in a lesser frequency.

Most popular intervention types in "Jagiellonian University" are "Device" (8 trials), "Procedure" (4 trials), "Drug" (3 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "doxorubicin hydrochloride" (2 trials), "radiation therapy" (2 trials), "surgery" (2 trials), "ATS 3f Enable Aortic Bioprosthesis Model 6000" (1 trials) and "Accu-Chek® Solo micropump system" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jagiellonian University" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Jagiellonian University". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Jagiellonian University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Jagiellonian University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".

Jagiellonian University has several departments that took part in Clinical trials: "Jagiellonian University Medical College, Department of Neurology" - 12 trials, "2nd Department of General Surgery, Jagiellonian University Medical College" - 5 trials, "Jagiellonian University, College of Medicine, Department of Endocrine Surgery, 3rd Chair of General Surgery" - 4 trials, "Jagiellonian University Dental Clinic" - 4 trials